MicroRNA-122 antagonism against hepatitis C virus genotypes 1–6 and reduced efficacy by host RNA insertion or mutations in the HCV 5′ UTR

od Li, Yi-Ping, Gottwein, Judith M., Scheel, Troels K., Jensen, Tanja B., Bukh, Jens
Izdano 2011

Production and Characterization of High-Titer Serum-Free Cell Culture Grown Hepatitis C Virus Particles of Genotype 1–6

od Mathiesen, Christian K., Jensen, Tanja B., Prentoe, Jannick, Krarup, Henrik, Nicosia, Alfredo, Law, Mansun, Bukh, Jens, Gottwein, Judith M.
Izdano u Virology (2014)

Adaptive Mutations Enhance Assembly and Cell-to-Cell Transmission of a High-Titer Hepatitis C Virus Genotype 5a Core-NS2 JFH1-Based Recombinant

od Mathiesen, Christian K., Prentoe, Jannick, Meredith, Luke W., Jensen, Tanja B., Krarup, Henrik, McKeating, Jane A., Gottwein, Judith M., Bukh, Jens
Izdano u J Virol (2015)

Efficient Culture Adaptation of Hepatitis C Virus Recombinants with Genotype-Specific Core-NS2 by Using Previously Identified Mutations

od Scheel, Troels K. H., Gottwein, Judith M., Carlsen, Thomas H. R., Li, Yi-Ping, Jensen, Tanja B., Spengler, Ulrich, Weis, Nina, Bukh, Jens
Izdano 2011

Hypervariable Region 1 Differentially Impacts Viability of Hepatitis C Virus Strains of Genotypes 1 to 6 and Impairs Virus Neutralization

od Prentoe, Jannick, Jensen, Tanja B., Meuleman, Philip, Serre, Stéphanie B. N., Scheel, Troels K. H., Leroux-Roels, Geert, Gottwein, Judith M., Bukh, Jens
Izdano 2011

Neutralizing Antibodies in Patients with Chronic Hepatitis C, Genotype 1, against a Panel of Genotype 1 Culture Viruses: Lack of Correlation to Treatment Outcome

od Pedersen, Jannie, Jensen, Tanja B., Carlsen, Thomas H. R., Schønning, Kristian, Christensen, Peer Brehm, Laursen, Alex Lund, Krarup, Henrik, Bukh, Jens, Weis, Nina
Izdano 2013

Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization

od Scheel, Troels K. H., Gottwein, Judith M., Jensen, Tanja B., Prentoe, Jannick C., Hoegh, Anne M., Alter, Harvey J., Eugen-Olsen, Jesper, Bukh, Jens
Izdano 2008

Adapted J6/JFH1-Based Hepatitis C Virus Recombinants with Genotype-Specific NS4A Show Similar Efficacies against Lead Protease Inhibitors, Alpha Interferon, and a Putative NS4A Inh...

od Gottwein, Judith M., Jensen, Sanne B., Serre, Stéphanie B. N., Ghanem, Lubna, Scheel, Troels K. H., Jensen, Tanja B., Krarup, Henrik, Uzcategui, Nathalie, Mikkelsen, Lotte S., Bukh, Jens
Izdano 2013

Development of a downstream process for the production of an inactivated whole hepatitis C virus vaccine

od Lothert, Keven, Offersgaard, Anna F., Pihl, Anne F., Mathiesen, Christian K., Jensen, Tanja B., Alzua, Garazi Peña, Fahnøe, Ulrik, Bukh, Jens, Gottwein, Judith M., Wolff, Michael W.
Izdano u Sci Rep (2020)

Development and Application of Hepatitis C Reporter Viruses with Genotype 1 to 7 Core-Nonstructural Protein 2 (NS2) Expressing Fluorescent Proteins or Luciferase in Modified JFH1 N...

od Gottwein, Judith M., Jensen, Tanja B., Mathiesen, Christian K., Meuleman, Philip, Serre, Stephanie B. N., Lademann, Jacob B., Ghanem, Lubna, Scheel, Troels K. H., Leroux-Roels, Geert, Bukh, Jens
Izdano 2011

Neutralization resistance of hepatitis C virus can be overcome by recombinant human monoclonal antibodies

od Pedersen, Jannie, Carlsen, Thomas H. R., Prentoe, Jannick, Ramirez, Santseharay, Jensen, Tanja B., Forns, Xavier, Alter, Harvey, Foung, Steven K. H., Law, Mansun, Gottwein, Judith, Weis, Nina, Bukh, Jens
Izdano u Hepatology (2013)